Skip to Content

Bolt Biotherapeutics Inc Ordinary Shares BOLT

Morningstar Rating
$1.21 +0.07 (6.14%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BOLT is trading at a 64% discount.
Price
$1.18
Fair Value
$1.74
Uncertainty
Extreme
1-Star Price
$91.62
5-Star Price
$1.36
Economic Moat
Yfyt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BOLT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.14
Day Range
$1.141.24
52-Week Range
$0.842.03
Bid/Ask
$1.22 / $1.29
Market Cap
$45.94 Mil
Volume/Avg
250,321 / 132,402

Key Statistics

Price/Earnings (Normalized)
Price/Sales
6.34
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
94

Valuation

Metric
BOLT
Price/Earnings (Normalized)
Price/Book Value
0.36
Price/Sales
6.34
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BOLT
Quick Ratio
6.38
Current Ratio
6.69
Interest Coverage
Quick Ratio
BOLT

Profitability

Metric
BOLT
Return on Assets (Normalized)
−29.66%
Return on Equity (Normalized)
−39.35%
Return on Invested Capital (Normalized)
−37.96%
Return on Assets
BOLT
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRXbft$550.4 Bil
VRTX
Vertex Pharmaceuticals IncCkpdgc$111.8 Bil
REGN
Regeneron Pharmaceuticals IncZsjqlsn$107.9 Bil
MRNA
Moderna IncBwlvc$36.3 Bil
ARGX
argenx SE ADRLcc$23.0 Bil
BNTX
BioNTech SE ADRRkzt$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncFhrmlxl$19.2 Bil
BMRN
Biomarin Pharmaceutical IncFkwpj$16.4 Bil
RPRX
Royalty Pharma PLC Class ABvnlh$13.4 Bil
INCY
Incyte CorpKyplhb$13.3 Bil

Sponsor Center